Author: Iain French - Page 2
Learn how to clearly communicate past drug reactions before surgery to prevent dangerous complications. From documenting symptoms to knowing who to tell and when, this guide gives you the exact steps to stay safe.
Never use kitchen spoons to give children medicine. Even small dosing errors can be dangerous. Learn why milliliters and oral syringes are the only safe way to measure pediatric medication.
Theophylline has a narrow therapeutic range and is easily affected by common medications like cimetidine, fluvoxamine, and allopurinol. Even small changes in metabolism can lead to life-threatening toxicity. Learn which drugs reduce clearance and how to prevent dangerous interactions.
Learn which postpartum pain medications are safe while breastfeeding and which ones to avoid. Get clear, science-backed advice on ibuprofen, acetaminophen, opioids, and timing your doses to protect your baby.
Learn how to reduce flatulence and GI side effects from acarbose and miglitol with practical tips on dosing, diet, probiotics, and over-the-counter remedies. Many patients find relief within weeks by adjusting their approach.
Sensorineural hearing loss is permanent inner ear damage caused by hair cell destruction. Learn what causes it, how it's diagnosed, and why hearing aids or cochlear implants are the only effective solutions.
Oral thrush is a common side effect of inhaled steroids, antibiotics, and immunosuppressants. Learn how nystatin and fluconazole work, which one to choose, and how to prevent recurrence with simple daily habits.
Stroke recovery isn't about waiting for healing-it's about actively rebuilding the brain through science-backed rehab. Learn the phases, therapies, and key factors that make real progress possible after brain injury.
MedWatch is the FDA's public safety reporting system for drugs, devices, and cosmetics. Learn how patients and providers can report adverse events, how the FDA uses these reports to protect public health, and why your report matters.
Apixaban and rivaroxaban are safe and effective at standard doses for obese patients, while dabigatran carries higher bleeding risks. Learn which DOACs work best and what to avoid in obesity.